1 |
Araki A, Sako Y (1987): Determination of free and total homocysteine in human plasma by high performance liquid chromatography with fluorescence detection. J Chromatogr 422 (27) : 43-52
DOI
PUBMED
ScienceOn
|
2 |
Lim HS, Heo YR (2002): Plasma total homocysteine, Folate and Vitamin Statues in Korean Adults. J Nutr Sci Vitaminol 48 (4): 290-297
DOI
ScienceOn
|
3 |
Pfeiffer CM (1998): Rapid and accurate HPLC assay for total plasma homocysteine and cysteine in a clinical Lab setting. FASEB J 12 (4): A550
|
4 |
Savage DG, Lindenbaum J, Stabler SP, Allen RH (1994): Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamine and folate deficiencies. Am J Med 96 (3) : 239-246
DOI
ScienceOn
|
5 |
Selhub J, Miller JW (1992): The pathogenesis of homocystemia: interruption of the coordinat regulation by S-adenosylmethionine of the remethylation and transsulfuration. Am J Clin Nutr 55 (1): 131-138
DOI
|
6 |
Willems FF, Aengevaeren WR, Boers GH, Blom HJ, Verheugt FW (2002): Coronary endothelial function in hyperhomocysteinemia: improvement after treatment with folic acid and cobalamin in patients with coronary artery disease. J Am Coil Cardiol 40(4): 766-772
DOI
ScienceOn
|
7 |
Heinecke JW, Rosen H, Suzuki LA, Chait A (1987): The role of sulfurcontaining amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. J Biol Chem 262(21): 10098-10103
|
8 |
Lentz SR. Sadler JE (1991): Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest 88(6): 1906-1914
DOI
PUBMED
|
9 |
McDonald L, Bray C, Field C, Love F, Davis B (1964): Homocystinuria, thrombosis and the blood-platelets. Lancet 15 (4) : 745-746
|
10 |
The Homocystein Lowering Trials' Collaboration (1998): Lowering blood homocysteine with folic acid based supplements: meta-analysis randomised trials. BMJ 316 (21): 894-898
DOI
ScienceOn
|
11 |
Nygard GN, Nordrehang E, Refsum H, Ueland PM, Farstad M. Vollset SE (1997): Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337 (4) : 230-236
DOI
PUBMED
ScienceOn
|
12 |
Ueland PM, Mansoor MA, Guttormsen AB, Muller F, Aukrust P, Refsum H, Svardal AM (1996): Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status-A possible element of the extracellular antioxidant defense system. J Nutr 126 (4): 1281S-1284S
|
13 |
Rodgers GM, Kane WH (1986): Activation of endogenous factor v by a homocysteine-induced vascular endothelial cell activator. J Clin Invest 77 (6) : 1909-1916
DOI
PUBMED
|
14 |
Robinson K, Arheart K, Refsum H, Brattstrom L, Boers G, Ueland P, Rubba P, Palma-Reis R, Meleady R, Daly L, Witteman J, Graham I (1998): Low circulating folate and vitamin concentrations: Risk factors for stroke, peripheral vascular disease, and coronary artery disease. COMAC group. Circulation 97 (5) : 437-443
DOI
ScienceOn
|
15 |
Mayer EL, Jacobsen DW. Robinson K (1996): Homocysteine and coronary atherosclerosis. JACC 27 (3): 517-527
DOI
ScienceOn
|
16 |
Naurath HJ, Joosten E. Riezler R. Stabler SP, Allen RH. Lindenbaum J (1995): Effect of vitamin folate, and vitamin supplements in elderly people with normal serum vitamin concentration. Lancet 346 (8967) : 85-88
DOI
ScienceOn
|
17 |
Tsai JC, Perrella MA, Yoshizumi M, Hsieh CM, Haber E, Schlegel R, Lee ME (1994): Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91 (14): 6369-6373
|
18 |
Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC (1996): Homocysteine metabolism and risk of myocardial infarction: Relation with vitamin , , and folate. Am J Epidemiol 143 (9): 845-859
|
19 |
Nygard O. Refsum H, Ueland PM, Vollset SE (1998): Major lifestyle determinants of plasma total homocysteine distribution: The Hordaland homocysteine study. Am J Clin Nutri 67 (2) : 263-270
DOI
|
20 |
Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995): A quantitative assessment of plasma homocysteine as a risk factor for . vascular disease. J Am Med Assoc 274(13): 1049-1057
DOI
ScienceOn
|
21 |
Woodside JV, Yarnell JW, McMaster D, Young IS, Harmon DL, McCrum EE, Patterson CC, Gey KF, Whitehead AS, Evans A (1998): Effect of group vitamins and antioxidant vitamins on hyperhomocysteinemia: A double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr 67 (5) : 858-866
DOI
|
22 |
Pancharuniti N, Lewis CA, Sauberlich HE, Perkins LL, Go RC, Alvarez JO. Macaluso M. Acton RT, Copeland RB. Cousins AL (1994): Plasma homocysteine. folate and vitamin concentrations and risk for early-onset coronary artery disease. Am J Clin Nutr 59 (4) : 940-948
DOI
|
23 |
Perterson JC, Spence JD (1998): Vitamins and progression of atherosclerosis in hyperhomocysteinemia. Lancet 351 (9098): 263
|
24 |
Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Hennekens CH (1992): A prospective study of plasma homocysteine and risk of myocardial infarction in US physition. JAMA 268(7): 877-881
DOI
ScienceOn
|
25 |
Israelsson B, Bratistrom LE. Hulberg BL (1998): Homocysteine and myocardial infarction. Theroscler 74: 227-233
|
26 |
Malinow MR (1996): Plasma homocyst (e) ine: a risk factor for arterial occlusive diseases. J Nutr 126 (4): 1238S-1243S
|
27 |
Vester B, Rasmussen K (1991): High performance liquid chromatography method for rapid and accurate determination of homocysteine in plasma and serum. Clin Biochem 29 (9) : 549-554
DOI
ScienceOn
|
28 |
Stabler SP, Marcell PD, Podell ER, Allen RH, Savage DG, Lindenbaum J (1988): Elevation of total homocysteine in the serum of patients with cobalamine or folate deficiency detected by capillary gas chromatography-mass spectrometry. J Clin Invest 81 (2): 466-474
DOI
PUBMED
|
29 |
Genest JJ, Mcnamara JR, Salem DN. Wilson PWF. Shaefer EJ, Malinow MR (1990): Plasma homocysteine levels in men with premature coronary artery disease. J Am Coli Cardiol 16(5): 1114-1119
DOI
|
30 |
Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991): Hyperhomocysteinernia: An independent risk factors for vascular disease. N Engl J Med 324 (17): 1149-1155
DOI
ScienceOn
|